Pabron Kids Cold Tablets (category II drug)

**Product Description**
A small, easy-to-swallow tablet-type cold medicine for children.

These are “Glace Coat Tablets,” a proprietary technology from Taisho Pharmaceutical, coated with a very thin sugar layer. This technology allows the tablets to remain small (approx. 7.0mm in diameter) while providing a slightly sweet, easy-to-swallow experience.
Can be taken by children 5 years of age and older.
Does not contain caffeine, dl-methylephedrine hydrochloride, or other substances that may disturb a child’s sleep.

**Precautions for Use**
**Contraindications**
(Failure to follow these instructions may result in worsening of current symptoms, side effects, or accidents.)
1. Do not take this product if you:
(1) Have ever had allergic symptoms due to this product or its ingredients.
(2) Have ever had asthma after taking this product, other cold medicines, or antipyretic analgesics.
2. While taking this product, do not use any of the following medications:
Other cold medicines, antipyretic analgesics, sedatives, antitussive expectorants, oral medications containing antihistamines (e.g., oral medications for rhinitis, motion sickness medication, allergy medication).
3. After taking this product, do not operate vehicles or machinery (drowsiness may occur).
4. Do not consume alcohol before or after taking this product.
5. Do not use this product for a prolonged period.

**Consultation**
1. The following individuals should consult a doctor, pharmacist, or registered seller before taking this product:
(1) Individuals undergoing treatment by a doctor or dentist.
(2) Pregnant women or those who may be pregnant.
(3) Individuals who have had allergic reactions to medications.
(4) Individuals with the following symptoms:
High fever, difficulty urinating
(5) Individuals with the following diagnoses:
Heart disease, liver disease, kidney disease, gastric/duodenal ulcer, glaucoma
2. If the following symptoms appear after taking this product, they may be side effects. Immediately stop taking the product and consult a doctor, pharmacist, or registered seller with this instruction leaflet.
Skin: Rash/redness, itching
Digestive system: Nausea/vomiting, loss of appetite
Psycho-neurological system: Dizziness
Urinary system: Difficulty urinating
Other: Excessive drop in body temperature
*In rare cases, the following serious symptoms may occur. In such cases, seek immediate medical attention.
Shock (anaphylaxis): Skin itching, hives, hoarseness of voice, sneezing, throat itching, difficulty breathing, palpitations, confusion of consciousness, etc., may appear immediately after taking the product.
Mucocutaneous-ocular syndrome (Stevens-Johnson syndrome), toxic epidermal necrolysis, acute generalized exanthematous pustulosis: High fever, bloodshot eyes, eye discharge, sores on the lips, sore throat, widespread skin rash/redness, small pustules on reddened skin, general malaise, loss of appetite, etc., may persist or worsen rapidly.
Drug-induced hypersensitivity syndrome: Widespread skin redness, systemic rash, fever, general malaise, swelling of lymph nodes (neck, armpits, groin, etc.), etc., may appear.
Liver dysfunction: Fever, itching, rash, jaundice (yellowing of skin and whites of eyes), brown urine, general malaise, loss of appetite, etc., may appear.
Kidney disorder: Fever, rash, decreased urine output, general swelling, general malaise, joint pain (aching joints), diarrhea, etc., may appear.
Interstitial pneumonia: Shortness of breath/difficulty breathing when climbing stairs or with slight exertion, dry cough, fever, etc., may appear suddenly or persist.
Asthma: Wheezing or whistling sounds when breathing, difficulty breathing, etc., may appear.
Aplastic anemia: Bruising, nosebleeds, bleeding gums, fever, pale skin and mucous membranes, fatigue, palpitations, shortness of breath, feeling unwell and dizzy, bloody urine, etc., may appear.
Agranulocytosis: Sudden high fever, chills, sore throat, etc., may appear.
3. After taking this product, the following symptoms may occur. If such symptoms persist or worsen, stop taking the product and consult a doctor, pharmacist, or registered seller with this instruction leaflet.
Dry mouth, drowsiness
4. If symptoms do not improve after taking 5-6 doses, stop taking the product and consult a doctor, pharmacist, or registered seller with this instruction leaflet.

**Indications and Effects**
Relief of various cold symptoms: fever, cough, runny nose, sore throat, sneezing, phlegm, nasal congestion, chills (due to fever), headache, joint pain, muscle pain.

**Dosage and Administration**
Take the following amount with water or lukewarm water, preferably within 30 minutes after a meal.

● 11 to 14 years of age
Dose per intake… 4 tablets
Doses per day… 3 times

● 7 to 10 years of age
Dose per intake… 3 tablets
Doses per day… 3 times

● 5 to 6 years of age
Dose per intake… 2 tablets
Doses per day… 3 times

● Under 5 years of age
Do not take.
(1) Strictly adhere to the prescribed dosage and administration.
(2) When administering to children, do so under the guidance and supervision of a guardian.
(3) How to remove tablets from the package:
Firmly press the convex part of the PTP sheet containing the tablet with your fingertip to break the aluminum foil on the back, and take out the tablet. (Swallowing the tablet in its packaging by mistake can lead to unexpected accidents, such as piercing the esophageal mucosa).

**Ingredients**
[Per 4 tablets]
Acetaminophen… 200mg
Tipepidine Hibenzate… 16.7mg
Guaifenesin… 33.3mg
Chlorpheniramine Maleate… 1.6mg
Additives: Cellulose, Anhydrous Silicic Acid, Magnesium Aluminometasilicate, Lactose, Carmellose Calcium, Hydroxypropyl Cellulose, Magnesium Stearate, Hypromellose, Sucrose, Titanium Dioxide, Iron Sesquioxide, Carnauba Wax, Fragrance, Vanillin, Benzyl Benzoate

**Storage and Handling Precautions**
(1) Store in a cool, dry place away from direct sunlight.
(2) Keep out of reach of children.
(3) Do not transfer to another container. (This may cause misuse or affect the quality of the product).
(4) Do not take the product after the expiration date.